Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Narcolepsy Type 2 (NT2)”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Large-scale testing (Phase 3)Looking for participantsNCT07502443
What this trial is testing

Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

Who this might be right for
Narcolepsy Type 2
Alkermes, Inc. 176
Large-scale testing (Phase 3)Looking for participantsNCT07598708
What this trial is testing

Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2
Centessa Pharmaceuticals (UK) Limited 222
Large-scale testing (Phase 3)Looking for participantsNCT07625280
What this trial is testing

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

Who this might be right for
NarcolepsyIdiopathic Hypersomnia
Jazz Pharmaceuticals 120
Large-scale testing (Phase 3)Looking for participantsNCT06767683
What this trial is testing

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia
Alkermes, Inc. 256
Testing effectiveness (Phase 2)Study completedNCT06555783
What this trial is testing

Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2

Who this might be right for
Narcolepsy Type 2
Alkermes, Inc. 93
Testing effectiveness (Phase 2)Looking for participantsNCT07493265
What this trial is testing

Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

Who this might be right for
Narcolepsy
Eisai Inc. 64
Testing effectiveness (Phase 2)Ended earlyNCT04096560
What this trial is testing

TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Who this might be right for
Narcolepsy Type 1 (NT1)Narcolepsy Type 2 (NT2)
Takeda 97
Not applicableLooking for participantsNCT07006233
What this trial is testing

A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia

Who this might be right for
Idiopathic HypersomniaNarcolepsy Type 1 (NT 1)Narcolepsy Type 2 (NT2)
University of Sydney 30
Testing effectiveness (Phase 2)Looking for participantsNCT07096674
What this trial is testing

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia
Centessa Pharmaceuticals (UK) Limited 90
Testing effectiveness (Phase 2)Looking for participantsNCT06952699
What this trial is testing

TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

Who this might be right for
Narcolepsy Type 2
Takeda 88